The FDA has announced that there is an increased risk of oral birth defects in children born to women taking Topamax during pregnancy. Data collected from a registry of pregnant women revealed a higher risk of cleft lip and cleft palate in infants whose mothers were being treated with Topamax or the generic Topiramate during pregnancy.
If you took this drug during pregnancy and delivered a child with Topamax birth defect, you may be entitled to financial compensation. Fill out our free case review form to find out if you can participate in a Topamax lawsuit to recover monetary damages for medical bills and other losses resulting from your child's Topamax birth defect.
According to information from the North American Antiepileptic Drug Pregnancy Registry, 1.4% of infants exposed to topiramate during pregnancy developed a cleft palate or cleft lip, whereas only .38-.55% of infants exposed to other epilepsy drugs developed an oral birth defect. Furthermore, the risk of oral birth defects was much lower (.07%) among children born to mothers who were not taking epilepsy drugs, such as Topamax, during pregnancy.
Cleft lip and cleft palate are types of topiramate birth defects which affect the upper lip and roof of the mouth. These Topamax birth defects develop when parts of the lip or palate do not fuse together during the first three months of pregnancy. The oral birth defects can range from a small notch in the lip to a groove which extends into the roof of the mouth and nose. Topamax birth defects can alter the child's face and may lead to difficulty eating and talking, as well as ear infections. Treatment for Topamax cleft palate and cleft lips typically involves corrective surgery.
Are you a Topamax user who bore a child with an oral birth defect? Contact our Topamax lawyers today for a free, no obligation review of your claim.
In response to the data regarding Topamax birth defects, the FDA will strengthen the label on Topiramate, a drug used to treat seizures associated with epilepsy and prevent migraines. The Topamax pregnancy warning has been updated from a category C to a category D risk, meaning that there is positive evidence of fetal risk based on human data.
The FDA warns that women of childbearing age and pregnant women should speak with their doctors about other treatment options to avoid taking Topamax or topiramate during pregnancy. Due to the risk of potential Topamax side effects during pregnancy, women should tell their doctor immediately if they become pregnant or plan to become pregnant while taking topiramate. However, people taking Topamax should not stop the drug unless instructed to do so by their physician.
Topamax and topiramate users who bore children with oral birth defects may be able to participate in a Topamax lawsuit to recover the cost of treatment, as well as other damages resulting from their child's Topamax birth defect. To find out if you are eligible for a Topamax lawsuit, complete our free, no obligation case evaluation form today. The Topamax litigation attorneys at Morgan and Morgan are providing this online legal consultation at no cost and remain dedicated to protecting the rights of women who bore children with Topamax birth defects.